Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-28

Clinical Trial Update: Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing polyglucoferron with intravenous ferric carboxymaltose and oral iron for preoperative treatment of iron deficiency anemia has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric carboxymaltose (ferric carboxymaltose)
  • Oral iron supplementation
  • Polyglucoferron

Snippet

Sponsor: Dr. Frank Behrens | Conditions: Iron Deficiency Anemia | Phase 3 | Status: WITHDRAWN